Gal-3 is a newly identified ligand of TREM-2 [7], and our studies showed increased levels of Gal-3 in both the cortex and hippocampus of the App KI mice, in agreement with upregulation in mouse and human post mortem AD brains [92, 100]. This evidence concerns the gene LGALS3 and Alzheimer disease.